Treatment of children with migraine in the emergency department a qualitative systematic review

Pediatric Emergency Care

Volumn 24, Issue 5, 2008, Pages 321-330

  Bailey, Benoit ^a,b   McManus, Barbara Cummins ^a  

^a Division of Emergency Medicine   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Adolescent; Migraine; Status migrainosus

Indexed keywords

DIHYDROERGOTAMINE; IBUPROFEN; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PROCHLORPERAZINE; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN; ANALGESIC AGENT; VASOCONSTRICTOR AGENT;

ANALGESIA; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG EFFICACY; EMBASE; EMERGENCY WARD; FOLLOW UP; HUMAN; MEDLINE; META ANALYSIS; MIGRAINE; QUALITATIVE ANALYSIS; RECURRENT DISEASE; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; TASTE DISORDER; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ADOLESCENT; CHILD; EMERGENCY HEALTH SERVICE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

ADOLESCENT; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; EMERGENCY SERVICE, HOSPITAL; HUMANS; MIGRAINE DISORDERS; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 46249096663     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e31816ed047     Document Type: Review

References (45)

1. Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ. 1994;309:765-769.
2. Sillanpaa M. Prevalence of headache in prepuberty. Headache. 1983;23:10-14.
3. Raieli V, Raimindo D, Cammalleri R, et al. Migraine headache in adolescents: a student population-based study in Montreal. Cephalalgia. 1995;15:5-12.
4. Kan L, Nagelberg J, Maytal J. Headaches in a pediatric emergency department: etiology, imaging, and treatment. Headache. 2000;40: 25-29.
5. Lewis DW, Qureshi F. Acute headache in children and adolescents presenting to the emergency department. Headache. 2000;40:200-203.
6. Loder E, Goldstein R, Biondi D. Placebo effects in oral triptan trials: the scientific and ethical rational for continued use of placebo controls. Cephalalgia. 2005;25:124-131.
7. Pryse-Phillips WEM, Dodick DW, Edmeads JG, et al. Guidelines for the diagnosis and management of migraine in clinical practice. CMAJ. 1997;156:1273-1287.
8. Ge'raud G, Lante'ri-Minet M, Lucas C, et al. French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther. 2004;26:1305-1310.
9. Lewis D, Ashwal A, Hershey A, et al. Practice parameters: Pharmacological treatment of migraine headache in children and adolescents. Neurology. 2004;63:2215-2224.
10. Silberstein S. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based-review). Neurology. 2000;6: 754-762.
11. Damen L, Bruijn J, Verhagen A, et al. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics. 2005;116:e295Ye302.
12. Hamalainen ML. Migraine in children and adolescents: a guide to drug treatment. CNS Drugs. 2006;20:813-820.
13. D'Amico D, Moshiano F, Usai S, et al. Treatment strategies in the acute therapy of migraine: stratified care and early intervention. Neurol Sci. 2006;27:S117YS122.
14. Cuvellier J, Joriot S, Auvin S, et al. Pharmacologic treatment of acute migraine attack in children. Arch Pediatr. 2004;12:316-325.
15. Lewis DW. Pediatric migraine. Pediatr Rev. 2007;28:43-52.
16. Kabbouche MA, Vockell AL, LeCates SL, et al. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics. 2001;107:e62.
17. Bulloch B, Teneibein M. Emergency department management of pediatric migraine. Pediatr Emerg Care. 2000;16:196-201.
18. Richer L, Graham L, Klassen TP, et al. Emergency department management of acute migraine in children in Canada: a practice variation study. Headache. 2007;47:703-710.
19. Major PW, Grubisa HS, Thie NM. Triptans for treatment of acute pediatric migraine: a systematic literature review. Pediatr Neurol. 2003;29:425-429.
20. Smith E, Cantrill S, Dalsey W, et al. Clinical policy for the initial approach to adolescents and adults presenting to the emergency department with a chief complaint of headache. Ann Emerg Med. 1996;27:821-843.
21. Barnes N, Millman G, James E. Migraine headache in children. Clin Evid. 2006;15:469-475.
22. Ryan S. Medicines for migraine. Arch Dis Child Educ Pract. 2007; 92:ep50Yep55.
23. Balottin U, Termine C. Recommendations for the management of migraine in paediatric patients. Exp Opin Pharmacother. 2007;8: 731-744.
24. Jadad AJ, Moore A, Carroll D, et al. Assessing the quality of reports of randomized clinical trial: is it necessary? Control Clin Trials. 1996;17:1-12.
25. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine second edition. Cephalalgia. 2000;20:765-786.
26. Lewis DW, Kellstein D, Dahl G, et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002; 42:780-786.
27. Hamalainen ML, Hoppu K, Valkeila E, et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997; 48:103-107.
28. Evers S, Rahmann A, Kraemer C, et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology. 2006;67: 497-499.
29. Hamalainen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology. 1997;48:1100-1103.
30. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999;52:1507-1510.
31. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000;106:989-997.
32. Ahonen K. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology. 2004;62:883-887.
33. Winner P, Rothner AD, Wooten JD, et al. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache. 2006;46:212-222.
34. Winner P, Lewis D, Visser WH, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache. 2002;42:49-55.
35. Visser WH, Winner P, Strohmaier K, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, singleattack study and two open-label, multiple-attack studies. Headache. 2004;44:891-899.
36. Ahonen K, Hamalainen ML, Eerola M, et al. A randomized trial of rizatriptan in migraine attacks in children. Neurology. 2006;67: 1135-1140.
37. Rothner AD, Wasiewski W, Winner P, et al. Zolmitriptan oral tablet in migraine treatment: high placebo response in adolescents. Headache. 2006;46:101-109.
38. Hamalainen ML, Hoppu K. Oral dihydroergotamine for therapy-resistant migraine attacks in children. Pediatr Neurol. 1997;16:114-117.
39. Brousseau DC, Duffy SJ, Anderson AC, et al. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004;43:256-262.
40. Headache classification committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(Suppl 7):1-96.
41. Headache classification subcommittee of the International Headache Society. International Classification of Headache Disorders. 2nd edition. Cephalalgia. 2004;24(Suppl 1):1-160.
42. Winner P, Wasiewski W, Gladstein J, et al. Multicentered prospective evaluation of proposed pediatric migraine revisions to the IHS criteria. Headache. 1997;37:545-548.
43. Prensky AL, Sommer D. Diagnosis and treatment of migraine in children. Neurology. 1979;29:506-510.
44. Hamalainen M, Jones M, Loftus J, et al. Sumatriptan nasal spray for migraine: a review of studies in patients aged 17 years and younger. Int J Clin Pract. 2002;56:704-709.
45. Cummins McManus B, Bailey B. Status migrainosus in children: a 3 year experience with prochlorperazine [abstract]. Pediatr Res. 2004; 55:108A.